SHANGHAI, June 18, 2026 – The 24th World Pharmaceutical Ingredients China (CPHI) was held at the Shanghai New International Expo Centre from June 16 to 18, 2026. The event brought together pharmaceutical ingredient suppliers and buyers from multiple countries and regions. Rensin Group, as one of the exhibitors, completed its 21st year of participation since first exhibiting in 2005.

During the exhibition, Rensin Group's booth was located at W2G33, covering an area of 72 square metres. Over the three‑day event, the booth received a steady flow of visitors from pharmaceutical companies across Europe, Southeast Asia, the Middle East, South America, and other markets. Long‑standing partners visited to discuss ongoing project progress, while new potential clients came to inquire about product specifications, pricing, and cooperation models.

From 2005 to 2026, Rensin Group's presence at CPHI spans more than two decades. This is not merely an accumulation of time, but a reflection of the company's continuous investment and stable operations in the active pharmaceutical ingredient (API) and intermediate sectors. Over the years, the pharmaceutical industry has experienced multiple cycles of adjustment, yet Rensin  Group has maintained an uninterrupted record at this global event.

This 21‑year track record demonstrates the company's accumulated strengths in product supply reliability, cost efficiency, and long‑term strategic vision. For partners, such consistent participation across industry cycles serves as a solid foundation of trust and dependability.

Rensin Group stated that its appearance at CPHI Shanghai 2026 is not an endpoint. The company will continue to participate in future CPHI events and has confirmed its attendance at CPHI Shenzhen, scheduled to take place at the Shenzhen Convention & Exhibition Center in September 2026. Looking ahead, Rensin Group remains focused on deepening its expertise in the API field and maintaining regular communication and collaboration with customers worldwide.